Autori: Dixon Mark
Naslov | Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial (Article) |
Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S ![]() |
Info | LANCET HAEMATOLOGY, (2017), vol. 4 br. 6, str. E272-E282 |
Projekat | F Hoffmann-La Roche |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|